Utah Medical Products, Inc.

NasdaqGS:UTMD Voorraadrapport

Marktkapitalisatie: US$217.7m

Utah Medical Products Inkomsten in het verleden

Verleden criteriumcontroles 3/6

Utah Medical Products is de winst gegroeid met een gemiddeld jaarlijks percentage van 6%, terwijl de Medical Equipment industrie de winst jaarlijks groeide met 12%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 2.4% per jaar. Het rendement op eigen vermogen van Utah Medical Products is 12.3%, en het heeft een nettomarge van 34.6%.

Belangrijke informatie

6.0%

Groei van de winst

6.6%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie8.9%
Inkomstengroei2.4%
Rendement op eigen vermogen12.3%
Nettomarge34.6%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Aug 06
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Utah Medical Products: An Attractive, But Speculative, Prospect

Mar 22

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Feb 09
Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Dec 13
Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Nov 23
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30

Nov 03
Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295

Aug 28
Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295

Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?

Mar 04
Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295

Feb 10
Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295

A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)

Jan 11
A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)

Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29

Aug 08
Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29

Utah Medical Products declares $0.29 dividend

Aug 02

Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M

Jul 26

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

May 14
Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29

Feb 26
Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Feb 12
Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital

Sep 28
Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28

Aug 06
Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28

Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation

May 01
Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation

Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?

Mar 26
Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?

Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital

Mar 02
Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 11
Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain

Jan 27
Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain

Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?

Jan 13
Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?

Dec 29
Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?

Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?

Dec 15
Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?

Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?

Nov 30
Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?

Utah Medical Products declares $0.285 dividend

Nov 03

Opbrengsten en kosten

Hoe Utah Medical Products geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

NasdaqGS:UTMD Opbrengsten, kosten en inkomsten (USD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 24441581
30 Jun 24471691
31 Mar 244916101
31 Dec 235017111
30 Sep 235117111
30 Jun 235217111
31 Mar 235217111
31 Dec 225216110
30 Sep 225216121
30 Jun 225116111
31 Mar 225015111
31 Dec 214915121
30 Sep 214814120
30 Jun 214613110
31 Mar 214211110
31 Dec 204211110
30 Sep 204212111
30 Jun 204413121
31 Mar 204715121
31 Dec 194715110
30 Sep 194514100
30 Jun 19431790
31 Mar 19421880
31 Dec 18421970
30 Sep 18421370
30 Jun 18421070
31 Mar 1842970
31 Dec 1741970
30 Sep 17401470
30 Jun 17401370
31 Mar 17391270
31 Dec 16391270
30 Sep 16401370
30 Jun 16401380
31 Mar 16401280
31 Dec 15401281
30 Sep 15411281
30 Jun 15411181
31 Mar 15411180
31 Dec 14411180
30 Sep 14411290
30 Jun 14401290
31 Mar 14401190
31 Dec 13401190

Kwaliteitswinsten: UTMD heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (34.6%) UTMD } zijn hoger dan vorig jaar (32.8%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: De winst van UTMD is de afgelopen 5 jaar met 6% per jaar gegroeid.

Versnelling van de groei: De winstgroei UTMD is het afgelopen jaar negatief geweest en kan daarom niet worden vergeleken met het 5-jarig gemiddelde.

Winst versus industrie: UTMD had het afgelopen jaar een negatieve winstgroei ( -9.7% ), waardoor het moeilijk is om te vergelijken met het branchegemiddelde Medical Equipment ( 10.4% ).


Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 12.3% ) van UTMD wordt als laag beschouwd.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden